AMERICAN JOURNAL OF CHINESE MEDICINE, published by WORLD SCIENTIFIC PUBL CO PTE LTD, is a leading peer-reviewed journal dedicated to the field of complementary and alternative medicine, with a particular focus on the rich traditions and practices of Chinese medicine. Since its establishment, the journal has provided a platform for innovative research and reviews that explore both empirical and theoretical aspects of Chinese medicinal practices, serving an essential role in bridging Eastern and Western medical paradigms. With an impressive impact factor, categorized in the Q1 quartile for both Complementary and Alternative Medicine and Medicine (miscellaneous) in 2023, it ranks as the 4th out of 105 journals in its field according to Scopus, placing it in the 96th percentile. Researchers and students alike will find valuable insights within its pages, as it aims to disseminate high-quality research that contributes to the understanding and application of Chinese medicine in modern healthcare contexts. The journal does not currently offer Open Access options but ensures rigorous academic standards and comprehensive reviews that reflect the evolving landscape of medicine. Located in Singapore, it has emerged as a vital resource for professionals seeking to enhance their knowledge and practice in the dynamic area of complementary health.

CURRENT PHARMACEUTICAL DESIGN is a leading journal in the fields of Drug Discovery and Pharmacology, published by Bentham Science Publishers Ltd in the dynamic United Arab Emirates. With an impressive historical span from 1995 to 2024, this journal serves as a vital platform for disseminating innovative research findings, breakthrough methodologies, and critical reviews that shape the future of pharmaceutical sciences. Ranked Q2 in both Drug Discovery and Pharmacology categories according to the 2023 metrics, it places itself within the top-tier percentile, catering to a diverse audience of researchers, industry professionals, and students. The journal’s commitment to high-quality research exploration is evidenced by its Scopus ranking, where it is positioned favorably within its category ranks. Although currently not Open Access, CURRENT PHARMACEUTICAL DESIGN remains an essential resource for those looking to stay at the forefront of pharmacological advancements and drug development strategies.

Journal of Pharmacy & Pharmacognosy Research, published by JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRES, is a prominent open-access journal established in 2013, headquartered in Antofagasta, Chile. With a focus on the fields of Complementary and Alternative Medicine, Drug Discovery, Pharmaceutical Science, Pharmacology, and Pharmacy, this journal is recognized for its commitment to advancing research and disseminating knowledge within these important areas. With a current impact factor that reflects its academic rigor and relevance, the journal has achieved substantial recognition, evident by its Q2 and Q3 quartile rankings in multiple categories, indicating its growing influence on the scientific community. The Scopus rankings further highlight its standing in pharmacy and pharmacological disciplines, providing a valuable platform for researchers, professionals, and students to share their findings and insights. With its open access model, the journal ensures that high-quality research is available to a global audience, paving the way for collaborative advancements in pharmaceutical sciences.

Asian Journal of Pharmaceutical Research and Health Care, published by Wolters Kluwer Medknow Publications, serves as a vital platform for disseminating cutting-edge research in the fields of pharmacology, toxicology, and healthcare. With an ISSN of 2250-1444 and an E-ISSN of 2250-1460, this journal aims to provide valuable insights and advancements in pharmaceutical sciences, targeting researchers, practitioners, and students dedicated to improving health outcomes. Although its coverage in Scopus was discontinued in 2016, the journal maintains importance within the academic community by fostering discourse and sharing knowledge on emerging topics. Despite its challenges reflected in the low Scopus ranking within its category, the Asian Journal of Pharmaceutical Research and Health Care remains committed to enhancing access to critical research and publishing high-quality work that bridges the gap between theory and practice in health care. Researchers and professionals engaged in the pharmaceutical field are encouraged to contribute and leverage this journal as a means to advance their work and elevate healthcare standards in Asia and beyond.

World Journal of Traditional Chinese Medicine, published by Wolters Kluwer Medknow Publications, is a prestigious open-access journal dedicated to advancing the field of Complementary and Alternative Medicine. Since its inception in 2014, this journal has provided a vital platform for researchers, practitioners, and students to share critical insights, original research, and reviews pertaining to Traditional Chinese Medicine (TCM). With an impressive impact factor, placing it in the Q1 category of the 2023 Scopus rankings for Complementary and Alternative Medicine, and ranked #23 out of 105 journals in this discipline, the World Journal of Traditional Chinese Medicine stands as a cornerstone for the promotion and acknowledgment of TCM in the global academic landscape. Operating from India, it fosters a collaborative community of scholars aiming to explore and expand the boundaries of knowledge in holistic health practices. The journal’s open-access model ensures that important research findings are readily accessible, promoting greater dissemination and engagement with traditional medical practices worldwide.

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.

Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.

Natural Product Communications is an esteemed open-access journal published by SAGE Publications Inc, dedicated to the exploration and dissemination of knowledge concerning natural products in diverse fields, including Complementary and Alternative Medicine, Drug Discovery, and Pharmacology. Since its inception in 2006 and continuing through its converged years until 2024, the journal has gained recognition with a robust focus on plant science and the medicinal properties of natural products. With a commendable impact factor reflected in its category quartiles (Q3 across key domains), Natural Product Communications serves as a vital resource for researchers and professionals who aim to further the understanding of the therapeutic potential of natural compounds. As an open-access journal since 2020, it ensures wide accessibility to its published research, thereby facilitating collaboration and innovation within the scientific community. This commitment to excellence makes Natural Product Communications a crucial platform for advancing research in the holistic and pharmacological sciences.

BIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.